Limited targeted radiation therapy after glioblastoma surgery
Part of Cancer clinical trials.
This trial tests a type of radiation therapy that uses a smaller, more focused area on the brain after surgery for glioblastoma. The goal is to see if this approach can reduce side effects while still controlling the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with glioblastoma and had surgery to remove as much of the tumor as possible.
- You are between 2 and 6 weeks after surgery.
- You are in good physical condition (able to care for yourself and do daily activities).
- Your blood tests for liver, kidney, and blood cell counts are mostly normal.
- You have not had radiation to the head before or been treated for another cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
This trial tests a shorter course of radiation therapy combined with the chemotherapy drug temozolomide for people with glioblastoma. It aims to see if this approach works as well as standard treatment while being more convenient.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
This study tests whether giving a higher dose of radiation to the tumor area improves outcomes for people with glioblastoma. It is for those who have had surgery or are planned for radiation, and have some remaining tumor.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This trial tests putting radiation directly into the brain right after surgery for glioblastoma, instead of waiting for standard radiation later. It aims to see if this approach works better and is safe for you.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.